特一藥業(002728.SZ)及下屬子(孫)公司累計捐贈現金55萬元及162.68萬元自產藥品
格隆匯2月17日丨特一藥業(002728.SZ)公佈,自新型冠狀病毒肺炎疫情發生以來,公司一直高度關注疫情發展,積極響應中央“疫情就是命令,防控就是責任”的號召,並投身到疫情防控工作中。
根據公司全資子公司海南海力製藥有限公司(“海力製藥”)所在海南省發佈的《海南省新型冠狀病毒感染的肺炎中醫藥防治方案》(“防治方案”),蒲地藍消炎片入選為防治方案的預防藥物。作為蒲地藍消炎片的生產廠家之一,為了支持海南省抗擊疫情,2020年2月17日,由公司全資子公司海力製藥及其子公司海南海力醫生藥業集團有限公司向海南省紅十字會達成捐贈意向,捐贈現金人民幣20萬元整、公司自產藥品總價值人民幣58.88萬元。其中捐贈的藥品包括:特一牌止咳寶片、特一牌蒲地藍消炎片。所捐贈的現金及藥品均用於海南省防控新型冠狀病毒感染的肺炎疫情方面支出與治療。
截至公告披露之日,公司及下屬子(孫)公司累計捐贈現金人民幣55萬元、自產藥品總價值人民幣162.68萬元,均用於支持抗擊新型冠狀病毒肺炎疫情。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.